Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: NASDAQ:), a biotechnology company...
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: NASDAQ:), a biotechnology company...
Investing.com– Australia’s trade balance grew slightly more than expected in June, aided by a steady...
Investing.com– Chinese manufacturing activity unexpectedly shrank in July, private purchasing managers index data showed on...
Merchants Bancorp (NASDAQ:) CEO Michael R. Dury has made a significant investment in the company’s...
BEIJING (Reuters) – China’s manufacturing activity in July shrank for the first time in nine...
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 31, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:) announced...
Venlo, the Netherlands, July 31, 2024 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime...
By Deisy Buitrago and Maria Ramirez CARACAS/PUERTO ORDAZ, Venezuela (Reuters) -Shops and public transport across...
By James Pomfret and Ismail Shakil TAIPEI/OTTAWA (Reuters) – A Canadian warship passed through the...